In a healthy adult with severe dental pain, which NSAID is preferred: ibuprofen or mefenamic acid?

Ibuprofen is Preferred Over Mefenamic Acid for Severe Dental Pain

For a healthy adult with severe dental pain, ibuprofen should be the first-line NSAID choice over mefenamic acid. This recommendation is based on superior gastrointestinal safety profile, extensive evidence supporting its use in dental pain, and current clinical practice guidelines.

Evidence-Based Rationale

Guideline Support for Ibuprofen

The most recent and authoritative guideline from 2025 explicitly recommends NSAIDs as first-line therapy for acute dental pain, with ibuprofen being the most extensively studied and recommended agent 1. This guideline emphasizes that NSAIDs alone or in combination with acetaminophen provide superior pain relief compared to opioids for dental extractions and toothache.

Among NSAIDs specifically, ibuprofen demonstrates superior gastrointestinal safety compared to other NSAIDs 2. The 2006 consensus development conference identified ibuprofen (along with etodolac and nabumetone) as having better GI safety profiles among non-selective NSAIDs, while drugs with prolonged half-lives and enterohepatic circulation—characteristics that apply to mefenamic acid—are associated with greater GI toxicity 2.

Clinical Evidence Comparison

While older studies from the 1980s-1990s showed mefenamic acid had analgesic efficacy for dental pain 3, 4, more recent systematic reviews question whether mefenamic acid offers any advantage over other NSAIDs 5. A 2007 literature review concluded there are no studies verifying mefenamic acid is more effective than other NSAIDs, and it may be less well-tolerated with more upper gastrointestinal lesions and occasional renal insufficiency 5.

The 2022 comparative analysis highlights that systemic toxicity with mefenamic acid begins at relatively low doses above the maximal daily dose, and there is "no reason to prefer mefenamic acid to other NSAIDs" 6.

Pharmacokinetic Considerations

Mefenamic acid has a 2-4 hour half-life and requires dosing every 6 hours 7. Its metabolites may accumulate in patients with renal or hepatic impairment 7. The drug undergoes extensive hepatic metabolism via CYP2C9 and is primarily renally excreted 7.

Practical Prescribing Algorithm

For severe dental pain in a healthy adult:

1. First-line: Ibuprofen 400-600 mg every 6-8 hours (maximum 2400 mg/day)

   • Superior GI safety profile 2
   • Extensive evidence base for dental pain 8, 1
   • Well-established dosing and safety parameters

2. Enhanced analgesia if needed: Ibuprofen + acetaminophen 1000 mg

   • Combination provides superior pain relief 1
   • Complementary mechanisms of action

3. Consider mefenamic acid only if:

   • Patient has documented superior response to mefenamic acid specifically
   • Other NSAIDs are contraindicated or ineffective
   • Dose: 500 mg initial, then 250 mg every 6 hours 7

Critical Safety Considerations

Avoid mefenamic acid in patients with:

• Pre-existing renal disease or significantly impaired renal function 7
• Hepatic dysfunction (requires dose reduction) 7
• Age >65 years (higher risk of adverse effects) 7
• History of GI ulcers or bleeding (higher risk than ibuprofen) 2, 5

Common pitfall: Prescribing mefenamic acid based on historical practice patterns rather than current evidence. The drug's popularity in some regions (like Austria) 6 reflects legacy prescribing rather than superior efficacy or safety.

Duration of therapy: Both agents should be prescribed on a fixed schedule, not "as needed" for the first 24-48 hours to maintain therapeutic levels and prevent breakthrough pain 8. Limit duration to 5-7 days maximum for acute dental pain.